On Wednesday, MKS received a positive adjustment to its Relative Strength (RS) Rating, from 78 to 81.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
History reveals that the best stocks often have an RS Rating north of 80 in the early stages of their moves.
MKS has moved more than 5% past a 107.88 entry in a first-stage consolidation, meaning it's now out of a proper buy range. Look for the stock to create a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
EPS growth decreased in the company's latest report from 45% to 12%, but revenue rose from 8% to 10%.
The company earns the No. 8 rank among its peers in the Electronics-Semiconductor Equipment industry group. Lam Research, ASML Holding and Nova are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
